The warnings, dated December 10, were issued to Prime Peptides, Summit Research Peptides, Swisschems and Xcel Research, all of which were found to be selling unapproved GLP-1 treatments that, despite being labelled as for research purposes, were marketed for human use
Differences between groups were analyzed using a Students t test (two-group comparisons) or one-way analysis of variance (multiple-group comparisons) with Tukeys post-hoc multiple comparisons test
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
However, little is known whether r-lipoic can be as effective therapy for certain diseases in human, especially the long term effect
Growth Hormone Receptor Upregulation BPC-157 increases the density of growth hormone receptors on tendon fibroblasts
The developing story of Sprouty and cancer